8-K: Exicure Inc. Announces 1-for-5 Reverse Stock Split to Regain Nasdaq Compliance

Exicure, Inc. will implement a 1-for-5 reverse stock split of its common stock to regain compliance with Nasdaq listing rules, effective August 27, 2024.

Summary

• Exicure, Inc. has announced a 1-for-5 reverse stock split of its outstanding common stock.
• The reverse stock split was approved by stockholders on August 20, 2024, and subsequently by the board of directors on the same day.
• The reverse stock split will be effective at 5:00 p.m. Eastern Time on August 27, 2024.
• Every five shares of common stock will be combined into one share.
• The number of outstanding shares will be reduced from approximately 8.65 million to approximately 1.73 million.
• The reverse stock split will not change the par value of the stock or the total number of authorized shares.
• No fractional shares will be issued; instead, stockholders will receive a full share in lieu of any fractional entitlement.
• The stock will begin trading on a split-adjusted basis on August 28, 2024, under the new CUSIP number 30205M309.
• The primary reason for the reverse stock split is to regain compliance with Nasdaq listing rules.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the reverse stock split is a necessary step to maintain listing compliance, it also indicates underlying issues with the company's stock price. The company is exploring strategic alternatives, which adds uncertainty.

Positives

• The reverse stock split is a step towards regaining compliance with Nasdaq listing rules.
• The reverse stock split will not affect the percentage ownership of stockholders, except for adjustments due to fractional shares.
• Stockholders will receive a full share in lieu of any fractional shares.

Negatives

• The reverse stock split is a result of the company's need to regain compliance with Nasdaq listing rules, which suggests previous issues with the stock price.
• The reverse stock split will reduce the number of outstanding shares, which may be perceived negatively by some investors.

Risks

• There is a risk that the company may not be able to cure existing listing deficiencies.
• There is a risk of additional deficiencies in the future.
• The company may not adequately comply with the terms of the Nasdaq panel's decision.
• There is a risk that Nasdaq will ultimately delist the company's common stock.

Future Outlook

The company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. There is no assurance regarding the company's ability to comply with Nasdaq listing criteria.

Management Comments

• The company is exploring strategic alternatives to maximize stockholder value.
• The reverse stock split is an effort to regain compliance with Nasdaq's listing rules.

Industry Context

Reverse stock splits are often used by companies to increase their stock price to meet minimum listing requirements, particularly on exchanges like Nasdaq. This action is common for companies facing delisting due to low share prices.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism for companies facing delisting from major exchanges like Nasdaq, similar to actions taken by other companies in the biotechnology sector when facing low stock prices.
• The 1-for-5 ratio is within the typical range for reverse stock splits, which can vary from 1-for-2 to 1-for-20 or more, depending on the specific circumstances of the company.
• Companies like Cassava Sciences and Ocugen have also recently undertaken reverse stock splits to maintain their Nasdaq listings, demonstrating the prevalence of this strategy in the biotech industry.

Corporate Governance

Stakeholder Impact

• Shareholders will see a reduction in the number of shares they own, but their percentage ownership will remain the same, except for adjustments due to fractional shares.
• The reverse stock split is intended to help the company maintain its Nasdaq listing, which is important for investor confidence.

Next Steps

• The company's stock will begin trading on a split-adjusted basis on August 28, 2024.
• The company will continue to explore strategic alternatives to maximize stockholder value.

Key Dates

Keywords

reverse stock split, Nasdaq compliance, stock split, common stock, listing rules, Exicure, XCUR